The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may also be relevant for outcome. Here we aimed at verifying the contribution of candidate polymorphisms of FCγ receptor, DNA repair and detoxification genes to prognostic stratification of follicular lymp...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Haematologica
Auteurs principaux: Rossi, Davide, Bruscaggin, Alessio, La Cava, Piera, Galimberti, Sara, Ciabatti, Elena, Luminari, Stefano, Rigacci, Luigi, Tucci, Alessandra, Pulsoni, Alessandro, Bertoldero, Giovanni, Vallisa, Daniele, Rusconi, Chiara, Spina, Michele, Arcaini, Luca, Angrilli, Francesco, Stelitano, Caterina, Merli, Francesco, Gaidano, Gianluca, Federico, Massimo, Palumbo, Giuseppe A.
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2015
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380725/
https://ncbi.nlm.nih.gov/pubmed/25596266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.108183
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires